Study to assess the safety and tolerability of CMR316 in healthy volunteers and patients with Idiopathic Pulmonary Fibrosis.
CBR-CMR316-3001
Phase 1 other active
Quick answer
Study to assess the safety and tolerability of CMR316 in healthy volunteers and patients with Idiopathic Pulmonary Fibrosis. for Idiopathic Pulmonary Fibrosis is a Phase 1 program (other) at The George Institute with 1 ClinicalTrials.gov record(s).
Program details
- Company
- The George Institute
- Indication
- Idiopathic Pulmonary Fibrosis
- Phase
- Phase 1
- Modality
- other
- Status
- active